THERAPEUTIC INFUSIONS Trademark

Trademark Overview


On Wednesday, September 14, 2022, a trademark application was filed for THERAPEUTIC INFUSIONS with the United States Patent and Trademark Office. The USPTO has given the THERAPEUTIC INFUSIONS trademark a serial number of 97590820. The federal status of this trademark filing is NEW APPLICATION - ASSIGNED TO EXAMINER as of Thursday, December 11, 2025. The THERAPEUTIC INFUSIONS trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Consulting services in the field of healthcare; Health care consulting in the field of ketamine treatment services and IV infusions health care, physical therapy
therapeutic infusions

General Information


Serial Number97590820
Word MarkTHERAPEUTIC INFUSIONS
Filing DateWednesday, September 14, 2022
Status638 - NEW APPLICATION - ASSIGNED TO EXAMINER
Status DateThursday, December 11, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesConsulting services in the field of healthcare; Health care consulting in the field of ketamine treatment services and IV infusions health care, physical therapy

Classification Information


International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, September 29, 2022
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNOT AVAILABLE
Party Type10 - Original Applicant
Legal Entity Type01 - Individual
AddressWilmington, DE 19806

Trademark Events


Event DateEvent Description
Saturday, September 17, 2022NEW APPLICATION ENTERED
Thursday, September 29, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, December 11, 2025ASSIGNED TO EXAMINER